CNS Research Peptides
Selank
C₃₃H₅₇N₁₁O₉
Key Research Findings
- Characterisation of the tuftsin-derived heptapeptide sequence.
- Published rodent BDNF transcription assay data.
- In-vitro IL-6 cytokine modulation studies.
Overview
Selank is a synthetic heptapeptide analogue of the endogenous tetrapeptide tuftsin. Supplied as a lyophilised powder for in-vitro research use only.
Mechanism of Action
Reported in published in-vitro and animal-model studies to interact with the GABAergic system and to modulate BDNF transcription in cell-line assays. Not intended for human or veterinary use.
Research Effects
GABAergic Modulation Studies
Extensive ResearchReported in animal-model studies as a modulator of GABA receptor pathway activity.
BDNF Transcription Studies
Moderate ResearchPublished cell-culture assays report effects on BDNF gene transcription.
Cytokine-Expression Studies
Moderate ResearchIn-vitro studies report modulation of IL-6 and related cytokines in macrophage assays.
Research Purposes Only — All information on this page is provided for scientific research purposes only. This product is not intended for human consumption, diagnosis, treatment, or prevention of any disease.
Quick Facts
Research Status Key
Featured in Bundles
Selank is included in the following Zenterex research peptide bundles.
Related Peptides
CNS Research Peptides
Semax
Semax is a synthetic heptapeptide analogue of the ACTH(4-10) fragment. Supplied as a lyophilised powder for in-vitro research use only.
Learn More →
CNS Research Peptides
DSIP
DSIP is a synthetic nonapeptide originally isolated from thalamic venous blood of rabbits. Supplied as a lyophilised powder for in-vitro research use only.
Learn More →